The Potential Role of HDAC1 and HDAC3 Immunoexpression in P53 Downregulation and Tumor Aggressiveness of Colon and Rectum Carcinomas Patients

The data on HDACs-p53 co-expression suggest a possible mechanism of interaction between the expression of these proteins.

Authors

Institutions

Publication Details

Journal
Experimental Oncology
Published
2025-02-20
DOI
https://doi.org/10.15407/exp-oncology.2024.04.393
Citations
2
Primary Topic
Histone Deacetylase Inhibitors Research
Type
article
Field-Weighted Citation Impact
1.61
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Potential Role of HDAC1 and HDAC3 Immunoexpression in P53 Downregulation and Tumor Aggressiveness of Colon and Rectum Carcinomas Patients

Kifah H. Abdulghafour, Yasir Qaddoori, Ahmed S. Al-Khafaji, Basim Mohammed Khashman
2 citations
Experimental Oncology
Histone Deacetylase Inhibitors Research
1.61
article

The Potential Role of HDAC1 and HDAC3 Immunoexpression in P53 Downregulation and Tumor Aggressiveness of Colon and Rectum Carcinomas Patients

Kifah H. Abdulghafour, Yasir Qaddoori, Ahmed S. Al-Khafaji, Basim Mohammed Khashman
article en
2 citations

Abstract

The data on HDACs-p53 co-expression suggest a possible mechanism of interaction between the expression of these proteins.

Experimental OncologyVol. 46(4)
University of Baghdad (IQ)
Good health and well-being
Openalex Percentile: Top 19%
Histone Deacetylase Inhibitors Research
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.